Additionally, this ADC utilized a chimeric ALK-directed antibody, which carries an immunogenicity risk compared to humanized antibodies due to the formation of human anti-mouse antibodies that leads to rapid clearance, poor tumor penetration, and hypersensitivity reactions34. This evidence concerns the gene ALK and neoplasm.